Feb. 13 | Virtual
Intellectual property (IP) migration is a common tax strategy used by life sciences companies. Such a strategy involves the transfer of IP from the company's US headquarters to a foreign related entity. Historically, we've seen this IP migration as a tax strategy, but the rules are complex. And the questions are many, particularly after the passage of tax reform. This webinar will provide an overview of the opportunities and challenges surrounding IP migration, both for those companies considering this strategy and those already having undertaken it. Learn more.

Full Story:
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information
that is changing your industry today, hand-curated by our professional editors from
thousands of sources and delivered straight to your inbox.